Responses to Genetic Risk Modifier Testing Among Women With BRCA1/2 Mutations
The purpose of this study is to describe how women with BRCA1/2 mutations react to genetic risk modifier testing, and to examine how they make decisions about their healthcare.
Study Start Date
January, 04 2018
Estimated Completion Date
- Other: Salvia sample
- Behavioral: Questionnaires
Memorial Sloan Kettering Cancer Center -- 17-489
Memorial Sloan Kettering Cancer Center
- Female MSK patient, age 25 years or older (given that women under this age are not generally recommended to receive BRCA1/2 genetic testing)
- Completed full sequence BRCA1/2 genetic testing with a deleterious BRCA1/2 mutation identified
- No personal history of breast cancer
- English-fluent the surveys were designed and validated in English and are not currently available in other languages. Translation of questionnaires into other languages would require reestablishing the reliability and validity of these measures. Therefore, participants must be able to communicate in English to complete the surveys.
- Previous receipt of any prophylactic mastectomy.
- Major psychiatric illness or cognitive impairment that in the judgment of the study investigators or study staff would preclude study participation.
- Any patients who are unable to comply with the study procedures as determined by the study investigators or study staff.
25 Years and older
Accepts Healthy Volunteers
Study Locations and Contact Information (5)
|Memorial Sloan Kettering Commack - Commack, New York||154.4 miles||Jada Hamilton PhD MPH||646-888-0049||None|
|Memoral Sloan Kettering Westchester - Harrison, New York||164.7 miles||Jada Hamilton PhD MPH||646-888-0049||None|
|Memorial Sloan Kettering Rockville Centre - Rockville Centre, New York||176.5 miles||Jada Hamilton PhD MPH||646-888-0049||None|
|Memorial Sloan Kettering Cancer Center - New York, New York||187.1 miles||Jada Hamilton PhD MPH||646-888-0049||None|
|Memorial SloanKettering at Basking Ridge - Basking Ridge, New Jersey||214.0 miles||Jada Hamilton PhD MPH||646-888-0049||None|